Braveheart Bio develops cardiac myosin inhibitors for hypertrophic cardiomyopathy, aiming to improve heart function while simplifying treatment and monitoring.
Braveheart Bio develops cardiac myosin inhibitors for hypertrophic cardiomyopathy, aiming to improve heart function while simplifying treatment and monitoring.